Gilead Sciences, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
GILD on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
333 Lakeside Dr, Foster City, CA

Insiders trading volume in the past year

Gilead Sciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Daniel P. O'Day Chairman & CEO, Director $80.5M -$5.6M -6.51% Sep 29, 2025
Andrew D. Dickinson Chief Financial Officer $23.5M -$56.3M -70.5% Sep 15, 2025
Merdad Parsey Chief Medical Officer $21.1M -$17.4M -45.3% Dec 10, 2024
Johanna Mercier Chief Commercial Officer $18.2M -$7.79M -30% Sep 15, 2025
Kevin E. Lofton Director $8.76M Mar 28, 2024
Olsen Per Wold Director $8.75M May 6, 2021
Deborah H. Telman EVP, Corporate Affairs & GC $8.74M Sep 10, 2025
Sandra Patterson SVP, Controllership $7.9M Mar 10, 2025
Dietmar Berger Chief Medical Officer $5.99M Mar 10, 2025
Diane E. Wilfong Interim Corp Controller & CAO $5.03M Sep 10, 2025
Brett A. Pletcher EVP,Corp Affairs & Gen Counsel $4.17M Jun 10, 2022
Jacqueline K. Barton Director $3.71M May 7, 2025
Richard James Whitley Director $3.15M May 6, 2021
Harish Manwani Director $2.4M May 7, 2025
Javier Rodriguez Director $2.27M May 7, 2025
Anthony Welters Director $2.22M May 7, 2025
Kelly A. Kramer Director $2.15M May 7, 2025
Sandra Horning Director $2.05M May 7, 2025
Ted W. Love Director $1.45M May 7, 2025
Jeffrey Bluestone Director $979K -$1.17M -54.4% Jul 14, 2025
Erin Burkhart SVP, Controllership Sep 22, 2025

Recent Insider Transactions by Companies or Individuals for Gilead Sciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.